Effect of ultrasounc-guided unilateral stellate ganglion block on perioperative autonomic nervous function after neoadjuvant chemotherapy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100049864

Enrollment

Unknown

Registered

2021-08-10

Start date

2021-08-16

Completion date

Unknown

Last updated

2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Experimental group1:Receiving 0.2% ropivacaine left SGB

Experimental group2:Received 0.2% ropivacaine right SGB

Control Group:Receive left or right equal volume of normal saline SGB

Eligibility

Sex/Gender

Female

Age

20 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. After neoadjuvant chemotherapy; 2. ASA I-III grade; 3. Aged 20 to 75 years.

Exclusion criteria

Exclusion criteria: 1. Neck skin infection; 2. Uncontrolled hypertension; 3. Sick sinus syndrome; 4. III degree or II degree type II atrioventricular block; 5. Coagulation disorders; 6. Patients who refuse to cooperate.

Design outcomes

Primary

Measure	Time frame
Heart rate variability;	—

Secondary

Measure	Time frame
Intraoperative blood pressure;	—

Countries

China

Contacts

Public ContactZeng Meina

Fujian Provincial Cancer Hospital

1169824783@qq.com+86 15659380497

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026